GGrantIndex
← Leaderboards

Chen Sabrina Tan

Beth Israel Deaconess Medical Center

$4,716,945
Attributed
$5,627,664
Total exposure
6
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $993.7K · FY200924
$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24

Funding mix

By agency

NIH$5,627,664 · 6

By mechanism

R01$1,821,439 · 1
R33$1,296,748 · 1
K02$867,769 · 1
K08$864,728 · 1
R21$776,980 · 2

Top collaborators

Most similar at Beth Israel Deaconess Medical Center

Same institution · by research overlap

Others in their field

Top investigators on “Immune Response

Research focus

Immune ResponseVirusBrainViralCellsProgressive Multifocal LeukoencephalopathyAutoimmune DiseasesMouse ModelImmuneNeuraxisJc VirusAntibodiesResponseBaseMediatingBloodEffective TherapyAnimalsVirus DiseasesMonoclonal AntibodiesImmunocompromised HostPreventLytic PhaseReceptor

Grant awards (22)

NK cell responses to JC polyomavirus$282,538
R01 · FY2024 · NS · contact PI
NK cell responses to JC polyomavirus$305,151
R01 · FY2023 · NS · contact PI
NK cell responses to JC polyomavirus$411,250
R01 · FY2022 · NS · contact PI
Antibody-based eradication of HIV from the CNS reservoirs$434,147
R33 · FY2021 · MH · contact PI
NK cell responses to JC polyomavirus$411,250
R01 · FY2021 · NS · contact PI
Characterization of broadly neutralizing antibodies against JC virus$144,245
K02 · FY2021 · NS · contact PI
Antibody-based eradication of HIV from the CNS reservoirs$438,176
R33 · FY2020 · MH · contact PI
NK cell responses to JC polyomavirus$411,250
R01 · FY2020 · NS · contact PI
Characterization of broadly neutralizing antibodies against JC virus$144,245
K02 · FY2020 · NS · contact PI
Antibody-based eradication of HIV from the CNS reservoirs$424,425
R33 · FY2019 · MH · contact PI
Characterization of broadly neutralizing antibodies against JC virus$193,093
K02 · FY2018 · NS · contact PI
Characterization of broadly neutralizing antibodies against JC virus$193,093
K02 · FY2017 · NS · contact PI
Antibody-based eradication of HIV from the CNS reservoirs$134,915
R21 · FY2017 · MH · contact PI
Mouse Model of Progressive Multifocal Leukoencephalopathy$217,500
R21 · FY2016 · NS · contact PI
Characterization of broadly neutralizing antibodies against JC virus$193,093
K02 · FY2016 · NS · contact PI
Antibody-based eradication of HIV from the CNS reservoirs$163,565
R21 · FY2016 · MH · contact PI
Mouse Model of Progressive Multifocal Leukoencephalopathy$261,000
R21 · FY2015 · NS · contact PI
JC Virus Primary Infection, Latency, and Reactivation$176,485
K08 · FY2013 · NS · contact PI
JC Virus Primary Infection, Latency, and Reactivation$176,485
K08 · FY2012 · NS · contact PI
JC Virus Primary Infection, Latency, and Reactivation$170,586
K08 · FY2011 · NS · contact PI
JC Virus Primary Infection, Latency, and Reactivation$170,586
K08 · FY2010 · NS · contact PI
JC Virus Primary Infection, Latency, and Reactivation$170,586
K08 · FY2009 · NS · contact PI